6 results
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... goals of assessing lung ... and relief of dyspnea ... Effusions #MPE #Algorithm
Causes of Interstitial Lung Disease - Differential Diagnosis Algorithm
Idiopathic Interstitial Pneumonia
 • (UIP) Usual Interstitial Pneumonia
slowly progressive dyspnea ... Primary - Other (Rare ... Atypical” Pneumonia Malignancy ... Radiaition • Drugs: Amiodarone ... , Beomycin • Acute
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Lung Toxicity Summary ... • Acutely (hours ... Dyspnea 3. ... embolism - Malignancy ... Pulmonary #diagnosis #management
Recurrent Polymorphic VT/Torsades de Pointes - Management Algorithm
Drugs that prolong QT interval:
 • Class 1a (quinidine,
Algorithm Drugs ... ) • Class 3 (amiodarone ... , sotalol) • Propofol ... 1b (lidocaine)- case ... #Algorithm
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Non-Infectious (NTBE): • Malignancy ... verrucous) • Lung ... Culture (+): Acute ... Heart Failure • Dyspnea ... Endocarditis #diagnosis #management